LeMaitre Vascular (NASDAQ:LMAT – Get Rating) updated its FY 2023 earnings guidance on Wednesday. The company provided EPS guidance of $1.14-$1.28 for the period, compared to the consensus EPS estimate of $1.16. The company issued revenue guidance of $187.10 million-$193.10 million, compared to the consensus revenue estimate of $176.11 million. LeMaitre Vascular also updated its […]
LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Rating) – Equities research analysts at KeyCorp upped their Q3 2023 earnings estimates for shares of LeMaitre Vascular in a note issued to investors on Tuesday, May 2nd. KeyCorp analyst M. Mishan now expects that the medical instruments supplier will earn $0.27 per share for the quarter, up from […]
LeMaitre Vascular (NASDAQ:LMAT – Get Rating) issued its quarterly earnings data on Tuesday. The medical instruments supplier reported $0.27 EPS for the quarter, beating the consensus estimate of $0.25 by $0.02, Briefing.com reports. The company had revenue of $47.08 million for the quarter, compared to analyst estimates of $43.54 million. LeMaitre Vascular had a return […]
LeMaitre Vascular (NASDAQ:LMAT – Get Rating) updated its second quarter 2023 earnings guidance on Wednesday. The company provided EPS guidance of $0.30-$0.35 for the period, compared to the consensus EPS estimate of $0.31. The company issued revenue guidance of $47.10 million-$49.50 million, compared to the consensus revenue estimate of $44.94 million. LeMaitre Vascular also updated […]
Geneva Capital Management LLC grew its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Rating) by 0.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 893,312 shares of the medical instruments supplier’s stock after acquiring an […]